FINLAB N (A7A.SG)
FINLAB N (A7A.SG) operates in Diversified Metals & Mining.
FINLAB N (A7A.SG) (A7A) - Total Liabilities
Latest total liabilities as of December 2023: €17.43 Million EUR
Based on the latest financial reports, FINLAB N (A7A.SG) (A7A) has total liabilities worth €17.43 Million EUR as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
FINLAB N (A7A.SG) - Total Liabilities Trend (2016–2023)
This chart illustrates how FINLAB N (A7A.SG)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
FINLAB N (A7A.SG) Competitors by Total Liabilities
The table below lists competitors of FINLAB N (A7A.SG) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RHOEN-KLINIKUM
MU:RHK
|
Germany | €530.90 Million |
|
HERBALIFE (HOO.SG)
STU:HOO
|
Germany | €3.61 Billion |
|
Legible Inc
PINK:LEBGF
|
USA | $6.15 Million |
|
TECHTRONIC IND
MU:TIB1
|
Germany | €6.65 Billion |
|
Roshni Capital Inc.
V:ROSH-P
|
Canada | CA$9.87K |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.52 Billion |
|
Nuveen California Select Tax Free Income Closed Fund
NYSE:NXC
|
USA | $795.79K |
Liability Composition Analysis (2016–2023)
This chart breaks down FINLAB N (A7A.SG)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 60.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how FINLAB N (A7A.SG)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for FINLAB N (A7A.SG) (2016–2023)
The table below shows the annual total liabilities of FINLAB N (A7A.SG) from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €17.43 Million | +781.52% |
| 2022-12-31 | €1.98 Million | -19.20% |
| 2021-12-31 | €2.45 Million | +3.80% |
| 2020-12-31 | €2.36 Million | -21.82% |
| 2019-12-31 | €3.02 Million | +51.58% |
| 2018-12-31 | €1.99 Million | -10.73% |
| 2017-12-31 | €2.23 Million | -47.39% |
| 2016-12-31 | €4.24 Million | -- |